Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C1OJ
|
||||
Former ID |
DIB011831
|
||||
Drug Name |
Debio-0930
|
||||
Synonyms |
MT-63-78; AMPK stimulator (oral, cancer), Mercury Therapeutics/Debiopharm SA; Adenosine monophosphate activated protein kinase stimulator (oral, cancer), Mercury Therapeutics/Debiopharm SA
|
||||
Indication | Metabolic disorders [ICD9: 270-279; ICD10:E70-E89] | Investigative | [543438] | ||
Company |
Mercury Therapeutics Inc
|
||||
Target and Pathway | |||||
Target(s) | AMP-activated protein kinase | Target Info | Stimulator | [543438] | |
KEGG Pathway | FoxO signaling pathway | ||||
Regulation of autophagy | |||||
mTOR signaling pathway | |||||
PI3K-Akt signaling pathway | |||||
AMPK signaling pathway | |||||
Circadian rhythm | |||||
Insulin signaling pathway | |||||
Adipocytokine signaling pathway | |||||
Oxytocin signaling pathway | |||||
Glucagon signaling pathway | |||||
Non-alcoholic fatty liver disease (NAFLD) | |||||
Hypertrophic cardiomyopathy (HCM) | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.